410 related articles for article (PubMed ID: 34237179)
1. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
[TBL] [Abstract][Full Text] [Related]
2. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
[TBL] [Abstract][Full Text] [Related]
3. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
[TBL] [Abstract][Full Text] [Related]
4. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.
Crane C; Phebus E; Ingulli E
Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992
[TBL] [Abstract][Full Text] [Related]
5. Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients.
Tsoutsoura P; Xagas E; Roussos S; Hatzakis A; Gourzi P; Boletis IN; Marinaki S
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374279
[No Abstract] [Full Text] [Related]
6. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.
Svorcova M; Novysedlak R; Lischke R; Vachtenheim J; Strizova Z
Front Immunol; 2022; 13():906225. PubMed ID: 35720376
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
Hansen CB; Jarlhelt I; Hasselbalch RB; Hamm SR; Fogh K; Pries-Heje MM; Møller DL; Heftdal LD; Pérez-Alós L; Sørensen E; Larsen MAH; Skjoedt MO; Ostrowski SR; Frikke-Schmidt R; Bayarri-Olmos R; Hilsted LM; Bundgaard H; Nielsen SD; Iversen KK; Garred P
J Intern Med; 2021 Dec; 290(6):1272-1274. PubMed ID: 34237190
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19.
Boyarsky BJ; Barbur I; Chiang TP; Ou MT; Greenberg RS; Teles AT; Krach MR; López JI; Garonzik-Wang JM; Avery RK; Massie AB; Segev DL; Werbel WA
Transplantation; 2021 Nov; 105(11):e270-e271. PubMed ID: 34284420
[No Abstract] [Full Text] [Related]
9. Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.
Yanis A; Haddadin Z; Spieker AJ; Waqfi D; Rankin DA; Talj R; Thomas L; Birdwell KA; Ezzell L; Blair M; Eason J; Varjabedian R; Warren CM; Nochowicz CH; Olson EC; Simmons JD; Yoder S; Guy M; Thomsen I; Chappell JD; Kalams SA; Halasa NB
Transpl Infect Dis; 2022 Feb; 24(1):e13772. PubMed ID: 34905653
[TBL] [Abstract][Full Text] [Related]
10. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
Front Immunol; 2022; 13():832501. PubMed ID: 35281023
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Hall VG; Ferreira VH; Ku T; Ierullo M; Majchrzak-Kita B; Chaparro C; Selzner N; Schiff J; McDonald M; Tomlinson G; Kulasingam V; Kumar D; Humar A
N Engl J Med; 2021 Sep; 385(13):1244-1246. PubMed ID: 34379917
[No Abstract] [Full Text] [Related]
12. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
Manothummetha K; Chuleerarux N; Sanguankeo A; Kates OS; Hirankarn N; Thongkam A; Dioverti-Prono MV; Torvorapanit P; Langsiri N; Worasilchai N; Moonla C; Plongla R; Garneau WM; Chindamporn A; Nissaisorakarn P; Thaniyavarn T; Nematollahi S; Permpalung N
JAMA Netw Open; 2022 Apr; 5(4):e226822. PubMed ID: 35412626
[TBL] [Abstract][Full Text] [Related]
13. Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.
Cao J; Liu X; Muthukumar A; Gagan J; Jones P; Zu Y
Clin Chem; 2021 Dec; 68(1):251-253. PubMed ID: 34358295
[No Abstract] [Full Text] [Related]
14. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
[TBL] [Abstract][Full Text] [Related]
15. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
Hoffman TW; Meek B; Rijkers GT; van Kessel DA
Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
[TBL] [Abstract][Full Text] [Related]
16. Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.
Al Jalali V; Scherzer S; Zeitlinger M
Clin Microbiol Infect; 2021 Oct; 27(10):1529-1530. PubMed ID: 34192576
[No Abstract] [Full Text] [Related]
17. Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.
Boyarsky BJ; Werbel WA; Avery RK; Tobian AAR; Massie AB; Segev DL; Garonzik-Wang JM
JAMA; 2021 May; 325(17):1784-1786. PubMed ID: 33720292
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.
Perrier Q; Lupo J; Gerster T; Augier C; Falque L; Rostaing L; Pelletier L; Bedouch P; Blanc M; Saint-Raymond C; Boignard A; Bonadona A; Noble J; Epaulard O
Vaccine; 2022 Oct; 40(44):6404-6411. PubMed ID: 36184404
[TBL] [Abstract][Full Text] [Related]
19. Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
Huang HJ; Yi SG; Mobley CM; Saharia A; Bhimaraj A; Moore LW; Kloc M; Adrogue HE; Graviss EA; Nguyen DT; Eagar TN; Jones SL; Ankoma-Sey V; MacGillivray TE; Knight RJ; Gaber AO; Ghobrial RM
Clin Transplant; 2022 May; 36(5):e14600. PubMed ID: 35083796
[TBL] [Abstract][Full Text] [Related]
20. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
